{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T00:56:08Z","timestamp":1795049768281,"version":"4.10.2"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T00:00:00Z","timestamp":1761436800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["PID2023\\u2013151726OA-I00"],"award-info":[{"award-number":["PID2023\\u2013151726OA-I00"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003751","name":"Gobierno de Espana Ministerio de Sanidad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003751","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008975","name":"Universitat de les Illes Balears","doi-asserted-by":"publisher","award":["ITS2023\\u201386"],"award-info":[{"award-number":["ITS2023\\u201386"]}],"id":[{"id":"10.13039\/501100008975","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008975","name":"Universitat de les Illes Balears","doi-asserted-by":"publisher","award":["BG22\/00037"],"award-info":[{"award-number":["BG22\/00037"]}],"id":[{"id":"10.13039\/501100008975","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Espa\u00f1a Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008062","name":"Fundaci\u00f3n Alicia Koplowitz","doi-asserted-by":"publisher","award":["RD24\/0003\/0007"],"award-info":[{"award-number":["RD24\/0003\/0007"]}],"id":[{"id":"10.13039\/100008062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008062","name":"Fundaci\u00f3n Alicia Koplowitz","doi-asserted-by":"publisher","award":["MICIU\/AEI\/10.13039\/501100011033"],"award-info":[{"award-number":["MICIU\/AEI\/10.13039\/501100011033"]}],"id":[{"id":"10.13039\/100008062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008062","name":"Fundaci\u00f3n Alicia Koplowitz","doi-asserted-by":"publisher","award":["PID2020\\u2013118582RB-I00"],"award-info":[{"award-number":["PID2020\\u2013118582RB-I00"]}],"id":[{"id":"10.13039\/100008062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.biopha.2025.118720","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T21:12:26Z","timestamp":1761858746000},"page":"118720","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Psilocybin as a fast-acting and long-lasting antidepressant for adolescence: Proposing NeuroD1 as a biomarker of its long-term plasticity"],"prefix":"10.1016","volume":"193","author":[{"given":"Rub\u00e9n","family":"Garc\u00eda-Cabrerizo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1602-3908","authenticated-orcid":false,"given":"Itziar","family":"Beruete-Fresnillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2173-8885","authenticated-orcid":false,"given":"Pedro","family":"Bergas-Cladera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Julia","family":"Garc\u00eda-Fuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.118720_bib1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/01.chi.0000184929.41423.c0","article-title":"10-year research update review: the epidemiology of child and adolescent psychiatric disorders: II. Developmental epidemiology","volume":"45","author":"Costello","year":"2006","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.biopha.2025.118720_bib2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0165-0327(02)00426-3","article-title":"Epidemiology of women and depression","volume":"74","author":"Kessler","year":"2003","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.biopha.2025.118720_bib3","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jad.2004.09.008","article-title":"Gender differences in depression: findings from the STAR*D study","volume":"87","author":"Marcus","year":"2005","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.biopha.2025.118720_bib4","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/s41386-018-0156-z","article-title":"Sex differences in antidepressant efficacy","volume":"44","author":"LeGates","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopha.2025.118720_bib5","doi-asserted-by":"crossref","first-page":"019","DOI":"10.17352\/2455-5460.000046","article-title":"A narrative review of major depressive disorder in children and adolescents","volume":"6","author":"Pratibha","year":"2020","journal-title":"Arch. Depress Anxiety"},{"key":"10.1016\/j.biopha.2025.118720_bib6","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S2215-0366(20)30307-2","article-title":"How mental health care should change as a consequence of the COVID-19 pandemic","volume":"7","author":"Moreno","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.biopha.2025.118720_bib7","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3389\/fpsyt.2020.00717","article-title":"Antidepressants in children and adolescents: meta-review of efficacy, tolerability and suicidality in acute treatment","volume":"11","author":"Boaden","year":"2020","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.biopha.2025.118720_bib8","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.neuint.2007.06.025","article-title":"Childhood and adolescent depression: why do children and adults respond differently to antidepressant drugs?","volume":"51","author":"Bylund","year":"2007","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.biopha.2025.118720_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107085","article-title":"Novel rapid treatment options for adolescent depression","volume":"201","author":"Ledesma-Corvi","year":"2024","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biopha.2025.118720_bib10","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.pharmthera.2003.11.002","article-title":"Hallucinogens","volume":"101","author":"Nichols","year":"2004","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.biopha.2025.118720_bib11","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.neuron.2007.01.008","article-title":"Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior","volume":"53","author":"Gonz\u00e1lez-Maeso","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.biopha.2025.118720_bib12","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyaf035","article-title":"Role of endogenous serotonin in psychedelic-like effects of psilocybin in mice","volume":"28","author":"Erkizia-Santamar\u00eda","year":"2025","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.biopha.2025.118720_bib13","doi-asserted-by":"crossref","first-page":"R63","DOI":"10.1016\/j.cub.2021.12.009","article-title":"Psychedelics","volume":"32","author":"Kelmendi","year":"2022","journal-title":"Curr. Biol."},{"key":"10.1016\/j.biopha.2025.118720_bib14","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/02791072.2019.1683260","article-title":"Psychedelic microdosing: a subreddit analysis","volume":"52","author":"Lea","year":"2020","journal-title":"J. Psychoact. Drugs"},{"key":"10.1016\/j.biopha.2025.118720_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-01811-4","article-title":"Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers","volume":"11","author":"Rootman","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.118720_bib16","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1017\/S1092852922000888","article-title":"Psilocybin in neuropsychiatry: a review of its pharmacology, safety, and efficacy","volume":"28","author":"Dodd","year":"2023","journal-title":"CNS Spectr."},{"key":"10.1016\/j.biopha.2025.118720_bib17","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cell.2020.03.020","article-title":"Psychedelic psychiatry\u2019s brave new world","volume":"181","author":"Nutt","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2025.118720_bib18","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa2032994","article-title":"Trial of psilocybin versus escitalopram for depression","volume":"384","author":"Carhart-Harris","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2025.118720_bib19","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1038\/s41386-023-01648-7","article-title":"Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication","volume":"48","author":"Goodwin","year":"2023","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopha.2025.118720_bib20","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/02698811211073759","article-title":"Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: prospective 12-month follow-up","volume":"36","author":"Gukasyan","year":"2022","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.biopha.2025.118720_bib21","article-title":"Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial","volume":"56","author":"von Rotz","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.biopha.2025.118720_bib22","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1001\/jama.2023.14530","article-title":"Single-dose psilocybin treatment for major depressive disorder: a randomized clinical trial","volume":"330","author":"Raison","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.biopha.2025.118720_bib23","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.medj.2024.01.005","article-title":"Psilocybin-assisted psychotherapy for treatment resistant depression: a randomized clinical trial evaluating repeated doses of psilocybin","volume":"5","author":"Rosenblat","year":"2024","journal-title":"Medicine"},{"key":"10.1016\/j.biopha.2025.118720_bib24","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1177\/02698811231154852","article-title":"Psilocybin-assisted therapy for major depressive disorder: an exploratory placebo-controlled, fixed-order trial","volume":"37","author":"Sloshower","year":"2023","journal-title":"J. Psychopharmacol."},{"issue":"10","key":"10.1016\/j.biopha.2025.118720_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26102948","article-title":"The Therapeutic potential of psilocybin","volume":"26","author":"Lowe","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2025.118720_bib26","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/0269881114565144","article-title":"Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study","volume":"29","author":"Bogenschutz","year":"2015","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.biopha.2025.118720_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2024.111243","article-title":"Early psilocybin intervention alleviates behavioral despair and cognitive impairment in stressed Wistar rats","volume":"136","author":"Wang","year":"2025","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.biopha.2025.118720_bib28","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1021\/acschemneuro.9b00493","article-title":"Psychedelics, but not ketamine, produce persistent antidepressant-like effects in a rodent experimental system for the study of depression","volume":"11","author":"Hibicke","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.biopha.2025.118720_bib29","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41398-025-03421-4","article-title":"Evaluation of behavioural and neurochemical effects of psilocybin in mice subjected to chronic unpredictable mild stress","volume":"15","author":"Erkizia-Santamar\u00eda","year":"2025","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.biopha.2025.118720_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2025.111249","article-title":"Clinical and preclinical evidence of psilocybin as antidepressant. A narrative review","volume":"136","author":"Erkizia-Santamar\u00eda","year":"2025","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.biopha.2025.118720_bib31","doi-asserted-by":"crossref","DOI":"10.1111\/fcp.70038","article-title":"Psilocybin as transformative fast-acting antidepressant: pharmacological properties and molecular mechanisms","volume":"39","author":"Adebo","year":"2025","journal-title":"Fundam. Clin. Pharm."},{"key":"10.1016\/j.biopha.2025.118720_bib32","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1080\/14740338.2023.2253144","article-title":"Is the psychedelic experience an essential aspect of the therapeutic effect of serotonergic psychedelics? Conceptual, discovery, development and implementation implications for psilocybin and related agents","volume":"22","author":"McIntyre","year":"2023","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.biopha.2025.118720_bib33","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2022489118","article-title":"Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice","volume":"118","author":"Hesselgrave","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2025.118720_bib34","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1021\/acsptsci.0c00192","article-title":"The subjective effects of psychedelics may not be necessary for their enduring therapeutic effects","volume":"4","author":"Olson","year":"2020","journal-title":"ACS Pharm. Transl. Sci."},{"key":"10.1016\/j.biopha.2025.118720_bib35","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41586-020-3008-z","article-title":"A non-hallucinogenic psychedelic analogue with therapeutic potential","volume":"589","author":"Cameron","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2025.118720_bib36","doi-asserted-by":"crossref","unstructured":"Sekssaoui M., Bockaert J., Marin P., B\u00e9camel C. Antidepressant-like effects of psychedelics in a chronic despair mouse model: is the 5-HT(2A) receptor the unique player? Neuropsychopharmacol. 2024;49:747-756.","DOI":"10.1038\/s41386-024-01794-6"},{"key":"10.1016\/j.biopha.2025.118720_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2025.116532","article-title":"Non-hallucinogenic psychedelics for mood and anxiety disorders: a systematic review","volume":"349","author":"Chen","year":"2025","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.biopha.2025.118720_bib38","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1021\/acsptsci.0c00194","article-title":"The subjective effects of psychedelics are necessary for their enduring therapeutic effects","volume":"4","author":"Yaden","year":"2020","journal-title":"ACS Pharm. Transl. Sci."},{"key":"10.1016\/j.biopha.2025.118720_bib39","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1021\/acschemneuro.2c00718","article-title":"5-HT2ARs mediate therapeutic behavioral effects of psychedelic tryptamines","volume":"14","author":"Cameron","year":"2023","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.biopha.2025.118720_bib40","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00221-013-3579-0","article-title":"Effects of psilocybin on hippocampal neurogenesis and extinction of trace fear conditioning","volume":"228","author":"Catlow","year":"2013","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.biopha.2025.118720_bib41","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1097\/CM9.0000000000002647","article-title":"Psilocybin facilitates fear extinction in mice by promoting hippocampal neuroplasticity","volume":"136","author":"Du","year":"2023","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.biopha.2025.118720_bib42","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s10020-024-01013-4","article-title":"Effects of psychedelics on neurogenesis and broader neuroplasticity: a systematic review","volume":"30","author":"Lima da Cruz","year":"2024","journal-title":"Mol. Med."},{"key":"10.1016\/j.biopha.2025.118720_bib43","doi-asserted-by":"crossref","DOI":"10.1038\/s41593-025-02021-1","article-title":"The psychoplastogen tabernanthalog induces neuroplasticity without proximate immediate early gene activation","author":"Aarrestad","year":"2025","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.biopha.2025.118720_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2024.111217","article-title":"The psychoplastogens ibogaminalog and ibogainalog induce antidepressant-like activity in na\u00efve and depressed mice by mechanisms involving 5-HT2A receptor activation and serotonergic transmission","volume":"136","author":"Arias","year":"2025","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.biopha.2025.118720_bib45","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1126\/science.adf0435","article-title":"Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors","volume":"379","author":"Vargas","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.biopha.2025.118720_bib46","doi-asserted-by":"crossref","first-page":"8221","DOI":"10.1038\/s41467-023-44016-1","article-title":"Identification of 5-HT2A receptor signaling pathways associated with psychedelic potential","volume":"14","author":"Wallach","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2025.118720_bib47","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41386-022-01389-z","article-title":"Towards an understanding of psychedelic-induced neuroplasticity","volume":"48","author":"Calder","year":"2023","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopha.2025.118720_bib48","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1196\/annals.1308.002","article-title":"Adolescent brain development and animal models","volume":"1021","author":"Spear","year":"2004","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1016\/j.biopha.2025.118720_bib49","article-title":"Adolescent development","author":"Backes","year":"2019"},{"key":"10.1016\/j.biopha.2025.118720_bib50","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1136\/bmj.330.7486.301","article-title":"Adolescent development","volume":"330","author":"Christie","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.biopha.2025.118720_bib51","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1111\/bph.15193","article-title":"The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research","volume":"177","author":"Percie du Sert","year":"2020","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.biopha.2025.118720_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2022.114262","article-title":"Effect of psilocybin on decision-making and motivation in the healthy rat","volume":"440","author":"Roberts","year":"2023","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.biopha.2025.118720_bib53","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1111\/bph.16466","article-title":"Pharmacological and behavioural effects of tryptamines present in psilocybin-containing mushrooms","volume":"181","author":"Rakoczy","year":"2024","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.biopha.2025.118720_bib54","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1007\/s00210-023-02778-x","article-title":"Ethopharmacological evaluation of antidepressant-like effect of serotonergic psychedelics in C57BL\/6J male mice","volume":"397","author":"Takaba","year":"2024","journal-title":"Naunyn Schmiede Arch. Pharm."},{"key":"10.1016\/j.biopha.2025.118720_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113612","article-title":"Serotonin 5-HT2A, 5-HT2c and 5-HT1A receptor involvement in the acute effects of psilocybin in mice. In vitro pharmacological profile and modulation of thermoregulation and head-twitch response","volume":"154","author":"Erkizia-Santamar\u00eda","year":"2022","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2025.118720_bib56","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/bph.15977","article-title":"Effects of repeated lysergic acid diethylamide (LSD) on the mouse brain endocannabinoidome and gut microbiome","volume":"180","author":"Inserra","year":"2023","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.biopha.2025.118720_bib57","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1177\/02698811241249436","article-title":"Psilocybin promotes neuroplasticity and induces rapid and sustained antidepressant-like effects in mice","volume":"38","author":"Zhao","year":"2024","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.biopha.2025.118720_bib58","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/s00213-024-06644-3","article-title":"Unraveling psilocybin's therapeutic potential: behavioral and neuroplasticity insights in Wistar-Kyoto and Wistar male rat models of treatment-resistant depression","volume":"242","author":"Kolasa","year":"2025","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopha.2025.118720_bib59","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.4088\/JCP.v67n1110","article-title":"Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder","volume":"67","author":"Moreno","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.biopha.2025.118720_bib60","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/nprot.2012.044","article-title":"Using the rat forced swim test to assess antidepressant-like activity in rodents","volume":"7","author":"Slattery","year":"2012","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.biopha.2025.118720_bib61","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.neuroscience.2015.07.040","article-title":"Hippocampal cell fate regulation by chronic cocaine during periods of adolescent vulnerability: consequences of cocaine exposure during adolescence on behavioral despair in adulthood","volume":"304","author":"Garc\u00eda-Cabrerizo","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopha.2025.118720_bib62","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1177\/0269881118812353","article-title":"Adolescent cocaine exposure enhanced negative affect following drug re-exposure in adult rats: attenuation of c-Fos activation","volume":"33","author":"Garc\u00eda-Cabrerizo","year":"2019","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.biopha.2025.118720_bib63","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00213-020-05689-4","article-title":"Increased negative affect when combining early-life maternal deprivation with adolescent, but not adult, cocaine exposure in male rats: regulation of hippocampal FADD","volume":"238","author":"Bis-Humbert","year":"2021","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopha.2025.118720_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2019.134625","article-title":"Adolescent morphine induces emotional signs of withdrawal paired with neurotoxicity selectively in male rats: female resilience","volume":"715","author":"Jim\u00e9nez-Romero","year":"2020","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.biopha.2025.118720_bib65","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.euroneuro.2020.10.008","article-title":"Sex differences in the antidepressant-like potential of repeated electroconvulsive seizures in adolescent and adult rats: regulation of the early stages of hippocampal neurogenesis","volume":"41","author":"Garc\u00eda-Cabrerizo","year":"2020","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.biopha.2025.118720_bib66","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1460-9568.2009.07045.x","article-title":"Impact of cocaine on adult hippocampal neurogenesis in an animal model of differential propensity to drug abuse","volume":"31","author":"Garc\u00eda-Fuster","year":"2010","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.biopha.2025.118720_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2023.1275783","article-title":"Electroconvulsive seizures regulate various stages of hippocampal cell genesis and mBDNF at different times after treatment in adolescent and adult rats of both sexes","volume":"16","author":"Ledesma-Corvi","year":"2023","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.biopha.2025.118720_bib68","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13293-016-0087-5","article-title":"Female rats are not more variable than male rats: a meta-analysis of neuroscience studies","volume":"7","author":"Becker","year":"2016","journal-title":"Biol. Sex. Differ."},{"key":"10.1016\/j.biopha.2025.118720_bib69","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1038\/s41386-019-0524-3","article-title":"Analysis of sex differences in pre-clinical and clinical data sets","volume":"44","author":"Beltz","year":"2019","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.biopha.2025.118720_bib70","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1016\/0024-3205(84)90436-3","article-title":"Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents","volume":"35","author":"Glennon","year":"1984","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2025.118720_bib71","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1007\/s00213-022-06106-8","article-title":"How to account for hallucinations in the interpretation of the antidepressant effects of psychedelics: a translational framework","volume":"239","author":"van den Berg","year":"2022","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopha.2025.118720_bib72","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1021\/acschemneuro.8b00101","article-title":"Dark classics in chemical neuroscience: N, N-Dimethyltryptamine (DMT)","volume":"9","author":"Cameron","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.biopha.2025.118720_bib73","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s43440-024-00636-y","article-title":"Fast-acting antidepressant-like effects of ketamine in aged male rats","volume":"76","author":"Hern\u00e1ndez-Hern\u00e1ndez","year":"2024","journal-title":"Pharm. Rep."},{"key":"10.1016\/j.biopha.2025.118720_bib74","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/s41398-022-01994-y","article-title":"Exploring pharmacological options for adolescent depression: a preclinical evaluation with a sex perspective","volume":"12","author":"Ledesma-Corvi","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.biopha.2025.118720_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117781","article-title":"Characterizing the therapeutical use of ketamine for adolescent rats of both sexes: antidepressant-like efficacy and safety profile","volume":"182","author":"Jornet-Plaza","year":"2025","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2025.118720_bib76","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1038\/s41380-023-02280-z","article-title":"Repeated low doses of psilocybin increase resilience to stress, lower compulsive actions, and strengthen cortical connections to the paraventricular thalamic nucleus in rats","volume":"28","author":"Kiilerich","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.biopha.2025.118720_bib77","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1021\/acschemneuro.2c00170","article-title":"Tolerance and cross-tolerance among psychedelic and nonpsychedelic 5-HT2A receptor agonists in mice","volume":"13","author":"de la Fuente Revenga","year":"2022","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.biopha.2025.118720_bib78","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/s00213-024-06644-3","article-title":"Unraveling psilocybin\u2019s therapeutic potential: behavioral and neuroplasticity insights in Wistar-Kyoto and Wistar male rat models of treatment-resistant depression","volume":"242","author":"Kolasa","year":"2025","journal-title":"Psychopharmacology"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222500914X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222500914X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:13:11Z","timestamp":1778544791000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222500914X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":78,"alternative-id":["S075333222500914X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118720","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psilocybin as a fast-acting and long-lasting antidepressant for adolescence: Proposing NeuroD1 as a biomarker of its long-term plasticity","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118720","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118720"}}